Clinical Trial Logistics Optimization: Best Practices for Pharma
Get tomorrow's supply chain signal
Daily supply-chain brief. Free, unsubscribe anytime.
The signal
Marken, a specialized logistics provider, has published guidance on clinical trial logistics optimization strategies. The article addresses a critical pain point for pharmaceutical and biotech companies: efficiently managing the complex, highly regulated movement of trial materials—including samples, investigational drugs, and biological specimens—across multiple geographies while maintaining strict temperature controls, chain-of-custody documentation, and compliance with regulatory requirements. For supply chain professionals, this topic matters because clinical trial logistics represents a specialized but high-stakes segment of pharma supply chains.
Trial materials often require point-to-point routing, real-time visibility, temperature excursion monitoring, and rapid response capabilities that differ significantly from commercial pharmaceutical distribution. Optimization in this area directly impacts trial timelines, costs, and the ability to recruit and retain clinical sites globally. Key implications include the need for robust vendor partnerships with specialized capabilities, investment in temperature monitoring and tracking technology, and integration of trial logistics planning into broader portfolio strategy.
As pharma R&D timelines remain compressed and global trial networks expand, logistics excellence becomes a competitive differentiator—not just a cost center.
Frequently Asked Questions
Get the daily supply chain briefing
Top stories, Pulse score, and disruption alerts. No spam. Unsubscribe anytime.
